Serum ferritin is a marker of morbidity and mortality in hemodialysis patients

American Journal of Kidney Diseases

Volumn 37, Issue 3, 2001, Pages 564-572

  Kalantar Zadeh, Kamyar ^a   Don, Burl R ^a   Rodriguez, Rudolph A ^a   Humphreys, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute phase reactant; Albumin; Anemia; Dialysis; Ferritin; Hospitalization; Mortality; Transferrin

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; FERRITIN; IRON;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; IRON STORAGE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RISK FACTOR;

EID: 0035123527     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.22433     Document Type: Article

References (30)

1. Iron status as measured by serum ferritin: The marker and its limitations
2. Diagnosis of iron deficiency in chronic renal failure
3. Serum ferritin and tissue iron in anemic dialysis patients
4. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
5. Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients
6. Iron treatment: Impact of safety issues
7. Diagnosis of hemochromatosis
8. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients
9. Acutephase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
10. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
11. Estimating sample size and power
12. Cohort studies
13. A clinical evaluation of serum ferritin as an index of iron stores
14. Review of issues relating to iron and infection
15. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: The Italian experience with 295 children
16. Serum ferritin as a clinical marker for renal cell carcinoma: Influence of tumor size and volume
17. Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators project
18. Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy
19. Ferritin
20. Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis
21. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1
22. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha
23. Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond
24. Iron management in endstage renal disease
25. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients
26. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients
27. A comparison between high values of serum C-reactive protein and ferritin as predictors of anemia, EPO resistance and malnutrition in dialysis patients
28. Acute-phase proteins and other systemic responses to inflammation
29. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
30. Effect of nutrition on morbidity and mortality in maintenance dialysis patients